Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fluorouracil
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : CBCC Global
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fluorouracil is a Cytotoxic Drug drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Keratosis, Actinic.
Product Name : Undisclosed
Product Type : Cytotoxic Drug
Upfront Cash : Inapplicable
October 15, 2021
Lead Product(s) : Fluorouracil
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : CBCC Global
Deal Size : Inapplicable
Deal Type : Inapplicable